Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 21 October 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.

Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.

Since the announcement as of 14 October 2019, the following transactions have been made:

 Number of
B shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement5,866,950 2,046,548,389
14 October 2019130,000352.5545,831,545
15 October 2019125,000354.5944,323,378
16 October 2019125,000354.1244,264,428
17 October 2019120,000355.3742,644,714
18 October 2019118,000352.5641,601,723
Accumulated under the programme6,484,950 2,265,214,177

The details for each transaction made under the share repurchase programme are published on novonordisk.com.

With the transactions stated above, Novo Nordisk owns a total of 37,044,994 B shares of DKK 0.20, corresponding to 1.5% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 18 October, Novo Nordisk has since 1 February 2019 repurchased a total of 29,885,962 B shares at an average share price of DKK 331.26 per B share equal to a transaction value of DKK 9,900,167,631.

Further information

Media:  
Anne Margrethe Hauge+45 4442 3450amhg@novonordisk.com
Ken Inchausti (US)+1 609 240 9429kiau@novonordisk.com
   
Investors:  
Peter Hugreffe Ankersen+45 3075 9085phak@novonordisk.com
Valdemar Borum Svarrer+45 3079 0301jvls@novonordisk.com
Ann Søndermølle Rendbæk+45 3075 2253arnd@novonordisk.com
Kristoffer Due Berg (US)+1 609 235 2989krdb@novonordisk.com
   

Company announcement no. 59 / 2019

Attachment